1-2 of 2
Robyn Haaf, BS
Close
Sort by
Journal Articles

Safety and Efficacy of Yttrium-90-Labeled Anti-CD45 Antibody ( 90 Y-DOTA-BC8) Followed By a Standard Reduced-Intensity Hematopoietic Stem Cell Transplant (HCT) Regimen for Patients with Refractory/Relapsed Leukemia or High-Risk Myelodysplastic Syndrome (MDS)

Phuong T. Vo, MD, Ted Gooley, PhD, Joseph G. Rajendran, MD, Darrell R. Fisher, PhD, Johnnie J. Orozco, MD PhD, Damian J. Green, MD, Ajay K. Gopal, MD, Robyn Haaf, BS, Margaret E. Nartea, BS, Rainer F. Storb, MD, Frederick R. Appelbaum, MD, Oliver W. Press, MD PhD, John M. Pagel, MD PhD, Brenda M. Sandmaier, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1018.
https://doi.org/10.1182/blood-2018-99-111915
Published: 2018
Journal Articles

Anti-CD45 Radioimmunotherapy Followed By Haploidentical Allogeneic Hematopoietic Cell Transplantation for Advanced Acute Leukemia or High-Risk MDS

Johnnie J. Orozco, MD PhD, Ted Gooley, PhD, Joseph G. Rajendran, MD, Darrell R. Fisher, PhD, H. Joachim Deeg, MD, Rainer F. Storb, MD, Raya Mawad, MD, Mazyar Shadman, MD, Ryan D. Cassaday, MD, Damian J. Green, MD, Ajay K. Gopal, MD, Brian G. Till, MD, Solomon Graf, MD, Robyn Haaf, BS, Sally J. Lundberg, Paul O'Donnell, MD, Oliver W. Press, MD PhD, Frederick R. Appelbaum, MD, John M. Pagel, MD PhD, Brenda M. Sandmaier, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2048.
https://doi.org/10.1182/blood.V130.Suppl_1.2048.2048
Published: 2017